Skip to main content
SpringerLink
Log in

Living unrelated—commercial—kidney transplantation: when there is no chance to survive

  • Editorial Commentary
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Transplantation is the best treatment of end-stage renal disease (ESRD); however, organ shortage is a reality. Deceased donor organ donation is inadequate; hence, the number of patients on the waiting lists is increasing progressively. Since many ESRD patients do not have living genetically related donors, living unrelated transplantation is considered. These transplantations offer excellent graft and patient survival rates if practiced in conventional situations, while the results are not so favorable or even poor in unconventional transplantations, which mostly take place in developing countries. Ethical aspects of living unrelated transplantation are more complicated than the medical side due to concern of commercialization. Making payment to the donors has been considered strictly as nonethical by many authors, while some others suggest reopening previous debates for kidney sales. The latter claim that if exploitation of donors is avoided, the reward (or payment) to the donor can be morally justified. Apart from these controversies, it is uniformly accepted that commercial transplantation is certainly unethical when brokers are involved or the aim is just profit for transplant physicians, because the main reason in favor of organ sales is improving the quality of life of the patients and the donors, not the brokers or the physicians. All these theoretical ethical arguments in the Western countries turn out to become vital concerns in developing countries, because transplantation is the cheapest renal replacement therapy. Recently, it has been suggested that organ shortage problems can partly be solved by establishing controlled donor compensation programs in these countries, which may also prevent exploitation of the donors. However, it is impossible to suggest a uniform solution for all countries because of deep differences in economical status as well as social and cultural values. Thus, every country should build its own ethical standards for commercial transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. US Renal Data System, USRDS Annual Data Report (2005) Atlas of end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD

  2. Chugh KS, Jha V (1996) Commerce in transplantation in Third World countries. Kidney Int 49:1181–1186

    Article  CAS  PubMed  Google Scholar 

  3. Ghods AJ (2002) Renal transplantation in Iran. Nephrol Dial Transplant 17:222–228

    Article  PubMed  Google Scholar 

  4. Otukesh H, Basiri A, Simfrosh N, Hoseini R, Sharifian M, Sadigh N, Golnari P, Rezai M, Fereshtenejad M (2006) Outcome of pediatric renal transplantation in Labfi Nejad Hospital, Tehran, Iran. Pediatr Nephrol (https://doi.org/10.1007/s00467-006-0184-5)

    Article  PubMed  Google Scholar 

  5. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S (1995) High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 333:333–336

    Article  CAS  PubMed  Google Scholar 

  6. Humar A, Durand B, Gillingham K, Payne WD, Sutherland DE, Matas AJ (2002) Living unrelated donors in kidney transplants: better long-term results than with non-HLA-identical living related donors? Transplantation 69:1942–1945

    Article  Google Scholar 

  7. Futagawa Y, Waki K, Gjertson DW, Terasaki PI (2005) Living-unrelated donors yield higher graft survival rates than parental donors. Transplantation 79:1169–1174

    Article  PubMed  Google Scholar 

  8. Salahudeen AK, Woods HF, Pingle A, Nur-El-Huda Suleyman M, Shakuntala K, Nandakumar M, Yahya TM, Daar AS (1990) High mortality among recipients of bought living-unrelated donor kidneys. Lancet 336:725–728

    Article  CAS  PubMed  Google Scholar 

  9. Chaballout A, Said R, Alboghdadly S, Huraib S, Selim H (1995) Living-related, cadaveric, and living unrelated donor kidney transplants: a comparison study at King Fahad Hospital, Riyadh. Transplant Proc 27:2775

    CAS  PubMed  Google Scholar 

  10. Colakoglu M, Akpolat T, Arik N, Utas C, Arinsoy T, Sindel S, Sungur C, Yasavul U, Turgan C, Caglar S (1995) Outcome of renal transplantation from foreign unrelated living donors in Turkey. Nephron 71:244–245

    Article  CAS  PubMed  Google Scholar 

  11. Mansy H, Khalil A, Aly TF, Filobbos P, al-Dusari S, al-Shareef Z, Shlash S (1996) Outcome of commercial renal transplantation: two years follow-up. Nephron 74:613–616

    Article  CAS  PubMed  Google Scholar 

  12. Frishberg Y, Feinstein S, Drukker A (1998) Living unrelated (commercial) renal transplantation in children. J Am Soc Nephrol 9:1100–1103

    CAS  PubMed  Google Scholar 

  13. Sever MS, Ecder T, Aydin AE, Türkmen A, Kilicaslan I, Uysal V, Eraksoy H, Çalangu S, Çarin M, Eldegez U (1994) Living unrelated (paid) kidney transplantation in Third-World countries: high risk of complications besides the ethical problem. Nephrol Dial Transplant 9:350–354

    CAS  PubMed  Google Scholar 

  14. Sever MS, Kazancioglu R, Yildiz A, Turkmen A, Ecder T, Kayacan SM, Celik V, Sahin S, Aydin AE, Eldegez U, Ark E (2001) Outcome of living unrelated (commercial) renal transplantation. Kidney Int 60:1477–1483

    Article  CAS  PubMed  Google Scholar 

  15. Turkmen A, Sever MS, Ecder T, Yildiz A, Aydin AE, Erkoc R, Eraksoy H, Eldegez U, Ark E (1996) Posttransplant malaria. Transplantation 62:1521–1523

    Article  CAS  PubMed  Google Scholar 

  16. Daar AS, Salahudeen AK, Pingle A, Woods HF (1990) Ethics and commerce in live donor renal transplantation: classification of the issues. Transplant Proc 22:922–924

    CAS  PubMed  Google Scholar 

  17. Divakar D, Thiagarajan CM, Reddy KC (1998) Ethical aspects of renal transplantation in India. Transplant Proc 30:3626

    Article  CAS  PubMed  Google Scholar 

  18. Cameron JS, Hoffenberg R (1999) The ethics of organ transplantation reconsidered: paid organ donation and the use of executed prisoners as donors. Kidney Int 55:724–732

    Article  CAS  PubMed  Google Scholar 

  19. The Council of the Transplantation Society (1985) Commercialisation in transplantation: the problems and some guidelines for practice. Lancet 2:715–716

    Google Scholar 

  20. World Health Organisation (1991) Guiding principles on human organ transplantation. Lancet 337:1470–1471

    Article  Google Scholar 

  21. Carpenter CB, Ettenger RB, Strom TB (1984) “Free-market” approach to organ donation. N Engl J Med 310:395–396

    CAS  PubMed  Google Scholar 

  22. Morris PJ, Sells RA (1985) Paying for organs from living donors. Lancet 1:1510

    Article  CAS  PubMed  Google Scholar 

  23. Abouna GM (1993) Negative impact of trading in human organs on the development of transplantation in the Middle East. Transplant Proc 25:2310–2313

    CAS  PubMed  Google Scholar 

  24. Radcliffe-Richards J, Daar AS, Guttmann RD, Hoffenberg R, Kennedy I, Lock M, Sells RA, Tilney N (1998) The case for allowing kidney sales. International Forum for Transplant Ethics. Lancet 351:1950–1952

    Article  CAS  PubMed  Google Scholar 

  25. Friedlander MM (2002). The right to sell or buy a kidney: are we failing our patients? Lancet 359:971–973

    Article  Google Scholar 

  26. Sakhuja V, Sud K (2003) End-stage renal disease in India and Pakistan: burden of disease and management issues. Kidney Int Suppl 83:S115–118

    Article  Google Scholar 

  27. Reddy KC (1993) Should paid organ donation be banned in India? To buy or let die! Natl Med J India 6:137–139

    CAS  PubMed  Google Scholar 

  28. Zargooshi J (2001) Iranian kidney donors: motivations and relations with recipients. J Urol 165:386–392

    Article  CAS  PubMed  Google Scholar 

  29. Choudhry S, Daar AS, Radcliffe Richards J, Guttmann RD, Hoffenberg R, Lock M, Sells RA, Tilney N (2003) Unrelated living organ donation: ULTRA needs to go. J Med Ethics 29:169–170

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Dossetor JB (2000) Kidney vending: “yes!” or “no!”. Am J Kidney Dis 35:1002–1018

    Article  Google Scholar 

  31. Davison AM (1994) Commercialization in organ donation. Nephrol Dial Transplant 9:348–349

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istanbul School of Medicine, Millet Cad., Capa, Sehremini, Istanbul, 34750, Turkey

    Mehmet Sukru Sever

Authors
  1. Mehmet Sukru Sever
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mehmet Sukru Sever.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sever, M.S. Living unrelated—commercial—kidney transplantation: when there is no chance to survive. Pediatr Nephrol 21, 1352–1356 (2006). https://doi.org/10.1007/s00467-006-0185-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-006-0185-4

Keywords

Search

Navigation